Correlation between androgen and estrogen receptor expression and clinicopathologic features in carcinoma urinary bladder
Authors:
- Nikita ShrivastavaNSNikita Shrivastava
- Rahul JenaRJRahul Jena
- Gautam Ram ChoudharyGCGautam Ram Choudhary
- Priyank BhargavaPBPriyank Bhargava
- Vikarn VishwajeetVVVikarn Vishwajeet
- Poonam ElhencePEPoonam Elhence
- Mahendra SinghMSMahendra Singh
- Deepak Prakash BhirudDBDeepak Prakash Bhirud
- Arjun Singh SandhuASArjun Singh Sandhu
- 5 September 2023
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (17) , 15795-15804
Abstract
Introduction The molecular mapping of cancers by the Cancer Genome Atlas Project has accelerated the quest for new therapeutic targets for urinary bladder cancer, including sex steroid receptors. Previous studies have demonstrated conflicting results on their relationship with bladder cancer, and there is sparse data on their expression in the Indian population. The aim of our study is to examine the expression of androgen receptors (AR) and estrogen receptors (ERα and ERβ) in patients with bladder cancer and their correlation with clinicopathologic features. Materials and methods In this retrospective cohort study, a total of 132 patients, who were surgically managed for urinary bladder mass by transurethral resection or radical cystectomy in our institute, with transitional cell carcinoma on histopathology and with at least two years of follow-up were included. Their demographic and treatment details were obtained, histopathology blocks were retrieved and immunohistochemical staining for androgen and estrogen receptors was performed. Then, the relationship between their expression and clinicopathologic features was studied. Results A total of 3.79% of patients showed estrogen receptor alpha positivity, 51.52% estrogen receptor beta positivity and 63.64% androgen receptor positivity. No statistically significant correlation was found between age of patients (p = 0.75/0.52/0.87), tumour stage and grade (0.71/0.3/0.21), pathological variant (p = 1/0.58/0.38) and overall survival (p = 0.70/0.052/0.45 for NMIBC and p = 0.82/0.36/0.22) and estrogen receptor alpha, estrogen receptor beta and androgen receptor-positive status, respectively. Estrogen receptor beta positivity was significantly higher in patients with unifocal (p = 0.015) and small tumours (< 5 cm) (p = 0.03), and its expression was associated with better disease-free survival (DFS) (p = 0.046) in patients of non-muscle invasive bladder cancer (NMIBC). Conclusion Our study has the largest sample size conducted on Indian population with results differing from previous studies conducted on western population. Estrogen receptor beta expression was significantly associated with small unifocal tumours and better DFS. Estrogen receptor alpha and androgen receptor expression were not found to be associated with the clinicopathologic features of the study population.Keywords
This publication has 24 references indexed in Scilit:
- Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analysesScientific Reports, 2016
- Cancer statistics, 2016CA: A Cancer Journal for Clinicians, 2016
- Prognostic Value of Sex-Hormone Receptor Expression in Non-Muscle-Invasive Bladder CancerYonsei Medical Journal, 2014
- Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladderBJU International, 2012
- Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: A comparative analysis of clinicopathological features and survival outcomes according to receptor expressionUrologic Oncology: Seminars and Original Investigations, 2011
- Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi‐institutional studyBJU International, 2010
- Female bladder cancer: incidence, treatment, and outcomeCurrent Opinion in Urology, 2010
- Estrogen and Progesterone Hormonal Receptor Expression in Urothelial Carcinoma of the BladderEuropean Urology, 2009
- Impact of age and gender on the clinicopathological characteristics of bladder cancerIndian Journal of Urology, 2009
- Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancerUrology, 2004